N4-acetylcytidine and other RNA modifications in epitranscriptome: insight into DNA repair and cancer development
Eva Bártová,
No information about this author
Lenka Stixová,
No information about this author
Alena Svobodová Kovaříková
No information about this author
et al.
Epigenomics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 12
Published: March 5, 2025
N4-acetylcytidine
(ac4C)
is
a
post-transcriptional
RNA
modification
that
plays
crucial
role
in
the
epitranscriptome,
influencing
gene
expression
and
cellular
function.
This
occurs
at
cytosine
base,
where
an
acetyl
group
installed
to
nitrogen
4th
position
(N4).
co-transcription
affects
stability,
structure,
translation
efficiency.
Recent
studies
have
uncovered
potential
link
between
modifications
DNA
repair
mechanisms,
suggesting
ac4C-modified
or
methylated
RNAs
may
interact
with
factors
involved
pathways;
thus,
response
damage.
Dysregulation
of
modified
RNAs,
including
ac4C
RNA,
has
been
implicated
cancer
development,
aberrant
levels
these
contribute
oncogenic
transformation
by
altering
genome
stability
key
genes
regulating
cell
proliferation,
cycle
progression,
apoptosis.
Understanding
dynamics
offers
promising
insights
into
epitranscriptome
processes
treatment.
Language: Английский
Toward the use of nanopore RNA sequencing technologies in the clinic: challenges and opportunities
Nucleic Acids Research,
Journal Year:
2025,
Volume and Issue:
53(5)
Published: Feb. 27, 2025
Abstract
RNA
molecules
have
garnered
increased
attention
as
potential
clinical
biomarkers
in
recent
years.
While
short-read
sequencing
and
quantitative
polymerase
chain
reaction
been
the
primary
methods
for
quantifying
abundance,
they
typically
fail
to
capture
critical
post-transcriptional
regulatory
elements,
such
modifications,
which
are
often
dysregulated
disease
contexts.
A
promising
cutting-edge
technique
method
that
addresses
this
gap
is
direct
sequencing,
offered
by
Oxford
Nanopore
Technologies,
can
simultaneously
both
abundance
modification
information.
The
rapid
advancements
platform,
along
with
growing
evidence
of
species
biofluids,
presents
a
compelling
opportunity.
In
review,
we
discuss
challenges
emerging
opportunities
adoption
nanopore
technologies
clinic,
highlighting
their
revolutionize
personalized
medicine
monitoring.
Language: Английский
Queuosine tRNA Modification: Connecting the Microbiome to the Translatome
BioEssays,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 26, 2024
ABSTRACT
Transfer
RNA
(tRNA)
modifications
play
an
important
role
in
regulating
mRNA
translation
at
the
codon
level.
tRNA
can
influence
selection
and
optimality,
thus
shifting
toward
specific
sets
of
mRNAs
a
dynamic
manner.
Queuosine
(Q)
is
modification
occurring
wobble
position.
In
eukaryotes,
queuosine
synthesized
by
tRNA‐guanine
trans
‐glycosylase
(TGT)
complex,
which
incorporates
nucleobase
queuine
(or
Qbase)
into
guanine
GUN
anticodons.
Queuine
sourced
from
gut
bacteria
dietary
intake.
Q
was
recently
shown
to
be
critical
for
cellular
responses
oxidative
mitochondrial
stresses,
as
well
its
potential
neurodegenerative
diseases
brain
health.
These
unique
features
provide
interesting
insight
regulation
bacteria,
health
implications.
this
review,
biology
examined
light
recent
literature
nearly
4
decades
research.
Q's
neuropsychiatric
cancer
highlighted
discussed.
Given
interest
Q,
new
findings,
more
research
needed
fully
comprehend
biological
function
disease
relevance,
especially
neurobiology.
Language: Английский
Closing in on human methylation—the versatile family of seven-β-strand (METTL) methyltransferases
Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 1, 2024
Abstract
Methylation
is
a
common
biochemical
reaction,
and
number
of
methyltransferase
(MTase)
enzymes
mediate
the
various
methylation
events
occurring
in
living
cells.
Almost
all
MTases
use
methyl
donor
S-adenosylmethionine
(AdoMet),
and,
humans,
largest
group
AdoMet-dependent
are
so-called
seven-β-strand
(7BS)
MTases.
Collectively,
7BS
target
wide
range
biomolecules,
i.e.
nucleic
acids
proteins,
as
well
several
small
metabolites
signaling
molecules.
They
play
essential
roles
key
processes
such
gene
regulation,
protein
synthesis
metabolism,
neurotransmitter
clearance.
A
decade
ago,
roughly
half
human
had
been
characterized
experimentally,
whereas
remaining
ones
merely
represented
hypothetical
predicted
from
bioinformatics
analysis,
many
which
were
denoted
METTLs
(METhylTransferase-Like).
Since
then,
considerable
progress
has
made,
function
>
80%
uncovered.
In
this
review,
I
provide
an
overview
(estimated)
120
MTases,
grouping
them
according
to
substrate
specificities
sequence
similarity.
also
elaborate
on
challenges
faced
when
studying
these
describe
recent
major
advances
field.
Language: Английский
Hydroxy‐wybutosine tRNA modifications as indicators of disease progression and therapeutic targets in leukaemia
Xu Chen,
No information about this author
Rui‐Ze Gong,
No information about this author
Liu‐Ying Mo
No information about this author
et al.
British Journal of Haematology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 10, 2024
Therapeutic
approaches
for
acute
myeloid
leukaemia
(AML)
and
myelodysplastic
syndromes
(MDS)
differ
due
to
distinct
diagnostic
criteria
treatment
strengths.
However,
reliable
biomarkers
differentiate
AML
from
MDS
are
needed.
This
study
investigated
transfer
RNA
(tRNA)
modifications,
particularly
hydroxy-wybutosine
(OHyW),
in
the
transition
AML.
We
found
a
significant
decrease
OHyW
its
biosynthetic
enzyme
leucine
carboxyl
methyltransferase
2
(LCMT2,
alias
symbol
is
TYW4)
levels
compared
MDS.
Mass
spectrometric
analysis
revealed
tRNA
modification
patterns,
with
showing
decreased
increased
precursor
levels,
indicating
disrupted
pathway.
Lower
LCMT2
expression
correlated
reduced
drug
sensitivity
limited
differentiation
potential
cell
lines.
The
results
highlight
pivotal
role
of
modifications
progression
suggest
that
targeting
may
enhance
therapeutic
outcomes
By
understanding
these
molecular
mechanisms,
we
can
develop
new
markers
strategies,
potentially
transforming
clinical
management
improving
patient
outcomes.
Language: Английский
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer
Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 26, 2024
Abstract
Messenger
RNA
(mRNA)
translation
is
a
tightly
controlled
process
frequently
deregulated
in
cancer.
Key
to
this
deregulation
are
transfer
RNAs
(tRNAs),
whose
expression,
processing
and
post-transcriptional
modifications
often
altered
cancer
support
cellular
transformation.
In
conditions
of
limiting
levels
amino
acids,
control
protein
synthesis
leads
aberrant
production
the
form
ribosomal
frameshifting
or
misincorporation
non-cognate
acids.
Here,
we
studied
leucine,
an
essential
acid
coded
by
six
different
codons.
Surprisingly,
found
that
leucine
deprivation
stalling
various
cell
types,
predominantly
at
one
codon,
UUA.
Similar
effects
were
observed
after
treatment
with
chemotherapeutic
agents,
implying
shared
mechanism
controlling
downstream
on
mRNA
translation.
both
conditions,
limitation
availability
tRNALeu(UAA)
for
was
shown
be
cause
dominant
effect
UUA
The
induced
proteins
can
processed
immune-presented
as
neoepitopes
direct
T-cell
killing.
Altogether,
uncovered
novel
mode
interplay
between
DNA
damage,
regulation
tRNA
could
exploited
anti-cancer
therapy.
Language: Английский
Editorial: Translational control in cancer
NAR Cancer,
Journal Year:
2024,
Volume and Issue:
6(3)
Published: July 9, 2024
Variation of tRNA modifications with and without intron dependency
Frontiers in Genetics,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 4, 2024
tRNAs
have
recently
gained
attention
for
their
novel
regulatory
roles
in
translation
and
diverse
functions
beyond
translation.
One
of
the
most
remarkable
aspects
tRNA
biogenesis
is
incorporation
various
chemical
modifications,
ranging
from
simple
base
or
ribose
methylation
to
more
complex
hypermodifications
such
as
formation
queuosine
wybutosine.
Some
are
transcribed
intron-containing
pre-tRNAs.
While
majority
these
modifications
occur
independently
introns,
some
catalyzed
an
intron-inhibitory
manner,
certain
cases,
they
intron-dependent
manner.
This
review
focuses
on
pre-tRNA
modification,
including
pre-tRNA,
both
fashions.
Any
perturbations
modification
processing
may
lead
a
range
diseases
disorders,
highlighting
importance
understanding
mechanisms
molecular
biology
medicine.
Language: Английский
ADAT2/3-mediated tRNA editing promotes cancer cell growth and tumorigenicity
Julia Ramírez-Moya,
No information about this author
Titi Rindi Antika,
No information about this author
Qi Liu
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 3, 2024
Abstract
Transfer
RNAs
(tRNAs)
are
subject
to
various
chemical
modifications
that
influence
their
stability
or
function.
Adenosine
Inosine
(A-to-I)
editing
in
the
tRNA
anticodon
at
position
A34
is
an
important
modification
expands
anticodon-codon
recognition
wobble
and
required
for
normal
mRNA
translation.
The
relevance
of
cancer
remains
unexplored.
Here
we
show
genes
encoding
ADAT2/3
deaminase
complex,
responsible
A-to-I
humans,
commonly
amplified
and/or
overexpressed
several
tumor
types
including
liposarcoma
(LPS).
We
find
knockdown
ADAT
complex
suppresses
LPS
cell
growth
tumorigenicity.
Mechanistically,
decreased
upon
ADAT2
depletion
leads
defective
translation
a
subset
mRNAs.
Thus,
ADAT-mediated
promotes
oncogenesis
by
enhancing
promoting
mRNAs
enriched
NNC
codons
lack
cognate
tRNAs
therefore
depend
on
A-I
decoding
Our
results
uncover
oncogenic
role
identify
as
potential
new
therapeutic
target.
Language: Английский